Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 10—October 2007

Personal Protective Equipment and Antiviral Drug Use during Hospitalization for Suspected Avian or Pandemic Influenza1

Ashwin Swaminathan*, Rhea Martin*, Sandi Gamon*, Craig Aboltins†, Eugene Athan‡, George Braitberg*, Michael G. Catton§, Louise Cooley¶, Dominic E. Dwyer#, Deidre Edmonds*, Damon P. Eisen**, Kelly Hosking*, Andrew J. Hughes‡, Paul D. Johnson*††, Andrew V Maclean‡‡, Mary O’Reilly‡‡, S. Erica Peters§§, Rhonda L. Stuart¶¶, Rodney Moran##, and M. Lindsay Grayson*††***Comments to Author 
Author affiliations: *Austin Health, Melbourne, Victoria, Australia; †St. Vincent’s Health, Melbourne, Victoria, Australia; ‡Barwon Health, Geelong, Victoria, Australia; §Victorian Infectious Diseases Reference Laboratory, Melbourne, Victoria, Australia; ¶Royal Hobart Hospital, Hobart, Tasmania, Australia; #Westmead Hospital, Sydney, New South Wales, Australia; **Royal Melbourne Hospital, Melbourne, Victoria, Australia; ††University of Melbourne, Melbourne, Victoria, Australia; ‡‡Box Hill Hospital–Eastern Health, Melbourne, Victoria, Australia; §§Western Hospital, Melbourne, Victoria, Australia; ¶¶Monash Medical Centre–Southern Health, Melbourne, Victoria, Australia; ##Department of Human Services, Melbourne, Victoria, Australia; ***Monash University, Melbourne, Victoria, Australia;

Main Article

Table 1

WHO Recommendations for HCW barrier precautions, dependent on type of exposure*†

HCW activity Recommended PPE set
Close contact (<1 m) with potential API-infected patient within or outside of the isolation room or area Gloves, gown, N95 mask (or equivalent particulate respirator), eye protection
Cleaning Gloves, either gown or apron
Patient transport within healthcare facilities Gown, gloves
Specimen transport and processing Not defined except to use “safe handling practices”; interpreted as use of gloves (minimum) and gown if opening specimen bag.

*WHO, World Health Organization; HCW, healthcare worker; PPE, personal protective equipment; API, avian or pandemic influenza.
†Derived from (7).

Main Article

  1. Meltzer  MI, Cox  NJ, Fukuda  K. The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis. 1999;5:65971. DOIPubMedGoogle Scholar
  2. World Health Organization Writing Group. Nonpharmaceutical interventions for pandemic influenza, national and community measures. Emerg Infect Dis. 2006;12:817.PubMedGoogle Scholar
  3. National Influenza Pandemic Action Committee. Interim infection control guidelines for pandemic influenza in healthcare and community settings. Annex to Australian health management plan for pandemic influenza, June 2006. [cited 2006 Jul 2]. Available from
  4. Department of Health and Ageing. Australian health management plan for pandemic influenza, May 2006. [cited 2006 May 15]. Available from$file/ahmppi-print.pdf
  5. Health Protection Agency. Guidance for pandemic influenza: infection control in hospitals and primary care settings, October 2005. [cited 2006 Oct 1]. Available from
  6. United States Department of Health and Human Services. HHS pandemic influenza plan supplement 4, infection control, November 2006. [cited 2006 November 20]. Available from
  7. World Health Organization. Avian influenza, including influenza A (H5N1) in humans: WHO interim infection control guidelines for health care facilities, 2006. [cited 2006 May 15]. Available from
  8. Brown  TL, Burrell  LJ, Edmonds  D, Martin  R, O’Keeffe  J, Johnson  P, Hand hygiene: a standardized tool for assessing compliance. Australian Infection Control. 2005;10:16.
  9. World Health Organization. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus, 2006. [cited 2006 Aug 20]. Available from
  10. Peiris  JS, Yuen  KY, Osterhaus  AD, Stöhr  K. The severe acute respiratory syndrome. N Engl J Med. 2003;349:243141. DOIPubMedGoogle Scholar
  11. Chan-Yeung  M. Severe acute respiratory syndrome (SARS) and healthcare workers. Int J Occup Environ Health. 2004;10:4217.PubMedGoogle Scholar
  12. Murphy  C. The 2003 SARS outbreak: global challenges and innovative infection control measures. Online J Issues Nurs [serial on the internet]. 2006 Jan 31. [cited 2006 Sep 1]. Available from
  13. Seto  WH, Tsang  D, Yung  RWH, Ching  TY, Ng  TK, Ho  M, Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet. 2003;361:151920. DOIPubMedGoogle Scholar
  14. Lau  JT, Fung  KS, Wong  TW, Kim  JH, Wong  E, Chung  S, SARS transmission among hospital workers in Hong Kong. Emerg Infect Dis. 2004;10:2806.PubMedGoogle Scholar
  15. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (based on data as of 31 December 2003). [cited 2006 Sep 1]. Available from
  16. Public Health Agency of Canada. Infection control and occupational health guidelines during pandemic influenza in traditional and non-traditional health care settings (annex F), June 2006. [cited 2006 Oct 1]. Available from

Main Article

1This research was presented in part at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, USA, September 17-20, 2007.

Page created: July 02, 2010
Page updated: July 02, 2010
Page reviewed: July 02, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.